Motova Plus
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
29-09-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
acetyl levocarnitine hydrochloride, Quantity: 500 mg; levocarnitine tartrate, Quantity: 1000 mg
Available from:
Vitex Pharmaceuticals Pty Ltd
Pharmaceutical form:
Tablet, film coated
Composition:
Excipient Ingredients: calcium hydrogen phosphate; Carnauba Wax; magnesium stearate; stearic acid; colloidal anhydrous silica; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000; lecithin; hyprolose; silicon dioxide; carmellose sodium
Administration route:
Oral
Therapeutic indications:
Maintain/support general health and wellbeing
Product summary:
Visual Identification: ;
Authorization status:
Listed
Authorization date:
2019-09-26
